市場調查報告書

白血球血球分離 (血液淨化療法) 市場 - 市場規模,佔有率,預測,機會分析:2020年∼2027年

Leukapheresis Market, by Device Type, By Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 968686
出版日期 內容資訊 英文 155 Pages
商品交期: 2-3個工作天內
價格
白血球血球分離 (血液淨化療法) 市場 - 市場規模,佔有率,預測,機會分析:2020年∼2027年 Leukapheresis Market, by Device Type, By Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年09月04日內容資訊: 英文 155 Pages
簡介

白血球血球分離 (血液淨化療法) ,是白血球由血液檢體分離的流程。全球白血球血球分離設備市場,由於白血病的盛行率增加,預計在預測期間內大幅度成長。

本報告提供全球白血球血球分離設備市場相關調查分析,市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 調查目的與前提條件

第2章 市場概要

  • 報告的說明
  • 摘要整理
  • 機會地圖(COM)

第3章 市場動態、規定、趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 影響分析
  • 技術的進步
  • 主要的發展
  • 收購、聯盟、夥伴關係
  • 流行病學
  • 法規方案
  • PEST分析
  • 波特的五力分析

第4章 COVID-19的影響分析

  • 供給方面分析
  • 需求面分析
  • 主要的發展

第5章 全球白血球血球分離設備市場:各設備類型

  • 簡介
  • 血球分離設備
  • 白血球血球分離管柱、分離設備
  • 白血球消除過濾器
  • 白血球血球分離拋棄式

第6章 全球白血球血球分離設備市場:各用途

  • 簡介
  • 研究用途
  • 治療用途

第7章 全球白血球血球分離設備市場:各終端用戶

  • 簡介
  • 醫院
  • 學術、研究機關
  • 製藥、生物科技企業
  • 血液成分供應商和血液中心

第8章 全球白血球血球分離設備市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 非洲
  • 中東

第9章 競爭情形

  • 企業簡介
    • Asahi Kasei Medical Co. Ltd.
    • Haemonetics Corporation
    • Terumo BCT Inc.
    • STEMCELL Technologies Inc.
    • Fresenius SE & Co. KGaA
    • BioIVT
    • Grifols, SA
    • Key Biologics, LLC

第10章 Section

目錄

Title:
Leukapheresis Market, by Device Type (Apheresis Devices, Leukapheresis Columns & Cell Separators, Leukoreduction Filters, and Leukapheresis Disposables), By Application (Research Applications and Therapeutic Applications), by End User (Hospitals, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Blood Component Providers and Blood Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Leukapheresis is a process, in which white blood cells are separated from a sample of blood. It is a specific type of apheresis used for separating a particular constituent of blood and returning the remaining part to the circulation. Leukapheresis is distinctly different from plasmapheresis and red cell exchange procedures.

Market Dynamics

The global leukapheresis devices market is expected to witness significant growth during the forecast period, owing to increasing prevalence of leukemia. For instance, according to the National Cancer Institute, in 2017, there were an estimated 434,982 people living with leukemia in the U.S. and according to the same source, the number of new cases of leukemia increased on an average rate of 0.3% each year over the last 10 years (from 2006 to 2015).

Key features of the study:

  • This report provides in-depth analysis of the global leukapheresis devices market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global leukapheresis devices market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc., Fresenius SE & Co. KGaA, BioIVT, Grifols, S.A, and Key Biologics, LLC
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics
  • The global leukapheresis devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for leukapheresis devices market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Leukapheresis Devices Market, By Device Type:
    • Apheresis Devices
    • Leukapheresis Columns & Cell Separators
    • Leukoreduction Filters
    • Leukapheresis Disposables
  • Global Leukapheresis Devices Market, By Application:
    • Research Applications
    • Therapeutic Applications
  • Global Leukapheresis Devices Market, By End User:
    • Hospitals
    • Academic and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Blood Component Providers and Blood Centers
  • Global Leukapheresis Devices Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Device Type:
    • Apheresis Devices
    • Leukapheresis Columns & Cell Separators
    • Leukoreduction Filters
    • Leukapheresis Disposables
      • By Application:
    • Research Applications
    • Therapeutic Applications
      • By End User:
    • Hospitals
    • Academic and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Blood Component Providers and Blood Centers
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Device Type:
    • Apheresis Devices
    • Leukapheresis Columns & Cell Separators
    • Leukoreduction Filters
    • Leukapheresis Disposables
      • By Application:
    • Research Applications
    • Therapeutic Applications
      • By End User:
    • Hospitals
    • Academic and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Blood Component Providers and Blood Centers
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Device Type:
    • Apheresis Devices
    • Leukapheresis Columns & Cell Separators
    • Leukoreduction Filters
    • Leukapheresis Disposables
      • By Application:
    • Research Applications
    • Therapeutic Applications
      • By End User:
    • Hospitals
    • Academic and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Blood Component Providers and Blood Centers
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Device Type:
    • Apheresis Devices
    • Leukapheresis Columns & Cell Separators
    • Leukoreduction Filters
    • Leukapheresis Disposables
      • By Application:
    • Research Applications
    • Therapeutic Applications
      • By End User:
    • Hospitals
    • Academic and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Blood Component Providers and Blood Centers
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
      • By Device Type:
    • Apheresis Devices
    • Leukapheresis Columns & Cell Separators
    • Leukoreduction Filters
    • Leukapheresis Disposables
      • By Application:
    • Research Applications
    • Therapeutic Applications
      • By End User:
    • Hospitals
    • Academic and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Blood Component Providers and Blood Centers
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
      • By Device Type:
    • Apheresis Devices
    • Leukapheresis Columns & Cell Separators
    • Leukoreduction Filters
    • Leukapheresis Disposables
      • By Application:
    • Research Applications
    • Therapeutic Applications
      • By End User:
    • Hospitals
    • Academic and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Blood Component Providers and Blood Centers
  • Company Profiles
    • Asahi Kasei Medical Co. Ltd.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Haemonetics Corporation
    • Terumo BCT Inc.
    • STEMCELL Technologies Inc.
    • Fresenius SE & Co. KGaA
    • BioIVT
    • Grifols, S.A
    • Key Biologics, LLC

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Device Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Technological Advancements
  • Key Developments
  • Acquisition, Collaborations & Partnerships
  • Epidemiology
  • Regulatory Scenario
  • Pest analysis
  • Porter's five forces analysis

4. Impact Analysis of Covid-19

  • Supply side Analysis
  • Demand Side Analysis
  • Key Developments

5. Global Leukapheresis Devices Market, By Device Type, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Apheresis Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Leukapheresis Columns & Cell Separators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Leukoreduction Filters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Leukapheresis Disposables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

6. Global Leukapheresis Devices Market, By Application, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Research Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Therapeutic Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Global Leukapheresis Devices Market, By End User, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Blood Component Providers and Blood Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

8. Global Leukapheresis Devices Market, By Region, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2027
    • Regional Trends
  • North America
    • Market Size and Forecast, By Device Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Device Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Device Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Device Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Device Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Device Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East

9. Competitive Landscape

  • Company Profiles
    • Asahi Kasei Medical Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Haemonetics Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Terumo BCT Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • STEMCELL Technologies Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Fresenius SE & Co. KGaA
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BioIVT
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Grifols, S.A
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Key Biologics, LLC
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact